|
|
|
|
|
|
|
|
|
09.01.26 - 15:54
|
US Adds Only 50K Jobs In December, Missing Estimates, But Unemployment Rate Drops To 4.4% (ZeroHedge)
|
|
|
US Adds Only 50K Jobs In December, Missing Estimates, But Unemployment Rate Drops To 4.4%
Ahead of today's jobs report, expectations were that the NFP number would show another rebound from the terrible Sept/Oct prints, but remain muted (or else spark fears about reheating and an end to the Fed's easing cycle). Well, that's precisely what we got moments ago when the BLS reported that in December the US gained 50K jobs, a modest miss to estimates of 50K, but smack in the middle of JPM's sweet spot range of 35K-75K (as previewed earlier) which would be best for the market.
The change in total nonfarm payroll employment for October was revised down by 68,000, from -105,000 to -173,000, and the change for November was revised down by 8,000, from +64,000 to +56,000. With these revisions, employment in October and November combined is 76,000 lower than previously reported. Notably, as shown in the chart below, the initial NFP print has now been revised lower in every single month of 2025.
While...
|
|
|
09.01.26 - 13:24
|
Expect Inflation to Peak at 3.6% by June: Pandit (Bloomberg)
|
|
|
Meera Pandit, Global Market Strategist at JPMorgan Asset Management, discusses inflation expectations, the state of the labor market and impacts from tariffs. She speaks to Bloomberg's Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern on 'Surveillance.' (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
09.01.26 - 10:03
|
Corporate News: EBD GmbH (EQS)
|
|
|
During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.01.26 - 15:06
|
Abstimmungsmanagement: J.P. Morgan Asset Management setzt auf KI statt Stimmrechtsberater (Das Investment)
|
|
|
Schluss mit Proxy-Beratern: J.P. Morgan setzt bei Aktionärsabstimmungen nun auf hauseigene KI statt ISS und Glass Lewis. Trump hatte die Branche zuvor scharf kritisiert.Die US-Großbank J.P. Morgan trennt sich von Proxy-Beratern und verlagert das Abstimmungsmanagement vollständig auf künstliche Intelligenz. Das Vermögensverwaltungshaus ist damit nach eigenen Angaben der erste große institutionelle Investor, der diesen Schritt geht, wie "CNBC" berichtet. In einem internen Memo teilte die Bank mit, künftig auf Datensammlung und Abstimmungsempfehlungen externer Berater zu verzichten. Stattdessen kommt das hauseigene......
|
|
|
08.01.26 - 14:18
|
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics (Business Wire)
|
|
|
Series A expected to advance lead asset Mucosal-Immune Modulator CS-0003 through Phase II in GI surgical site infections and expand a differentiated GI mucosal-immune pipeline and metabolomics-driven discovery platformNORTH CHICAGO, Ill.--(BUSINESS WIRE)--32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 million Series A financing during the 2026 J.P. Morgan Healthcare Conference (January 12–15, 2026).
The Series A financing is intended to advance CS-0003, a first-in-class Mucosal-Immune Modulator (MIM) designed to buffer the GI tract by coating and protecting the mucosal barrier, suppressing bacterial virulence, and modulating the mucosal-immune system. The lead indication is prevention of gastrointestinal surgical site infections (GI SSI), with potential expansion into inflammatory bowel disease (IBD) and prevention of colon cancer recurrence, where mucosal...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
